February 24 – 25, 2011 in London , United Kingdom ~

CBI’s 6th Forum on Late Phase Research, Drug Safety and Risk Management re-convened industry thought-leaders to discuss new challenges and opportunities within Phase IV and observational studies.

The 2010 agenda featured valuable perspectives from 12 industry speakers including senior level executives from Roche, Cephalon, Bayer, Biogen Idec, Pfizer, Shire, etc.

To remain at the forefront of the industry, CBI continues to monitor the evolving landscape for late phase studies in preparation for our 7th annual event.

(More)